Genetic Mutation Identified as Cause of Fatty Liver Disease

Researchers at Mayo Clinic's Center for Individualized Medicine have uncovered a rare inherited genetic mutation that can directly lead to metabolic dysfunction-associated steatotic liver disease, previously known as nonalcoholic fatty liver disease (NAFLD). This groundbreaking discovery challenges the previous understanding that the disease primarily results from a combination of genetic and environmental factors, highlighting that in some instances, a single genetic variant can be the main cause.
The identified mutation occurs in the MET gene, which plays a crucial role in liver repair and fat metabolism. When this gene malfunctions due to the mutation, it causes an abnormal buildup of fat within liver cells. This accumulation triggers inflammation and, over time, leads to fibrosis and scarring, ultimately stiffening the liver tissue. If untreated, this process can progress to cirrhosis, which may cause irreversible liver damage or even liver cancer.
Metabolic dysfunction-associated steatotic liver disease affects approximately one-third of adults worldwide. Its severe form, known as metabolic dysfunction-associated steatohepatitis, is poised to become the leading cause of cirrhosis and a major reason for liver transplants in the near future.
The discovery was made through analysis of genomic data from a woman and her father, both affected by the disease but without common risk factors such as diabetes or high cholesterol. By examining over 20,000 genes, scientists identified a tiny, yet impactful, error in the MET gene—a single letter change in the DNA sequence—that disrupted normal fat processing in the liver. This mutation was unique and had not been documented before in existing literature or databases.
In collaboration with the Medical College of Wisconsin, researchers found that this genetic error affected a critical biological process, preventing the liver from metabolizing fat properly. This finding emphasizes that rare genetic variants can profoundly influence common diseases, often remaining hidden within complex disorders.
Further investigations using Mayo Clinic’s extensive genomic database, the Tapestry study, revealed that about 1% of individuals with this liver condition carry similar rare variants in the MET gene. Nearly 18% of those studied displayed variants in the same region, reinforcing the gene's role in disease development.
This research underscores the importance of integrating genomics into clinical care, as it allows for the identification of genetic causes of diseases that were previously considered multifactorial. Since 2019, Mayo Clinic's Program for Rare and Undiagnosed Diseases has provided advanced genomic testing to over 3,200 patients with complex conditions, supporting this precision medicine approach.
Future studies aim to explore how understanding these genetic factors can lead to targeted therapies and more effective disease management strategies. Overall, this discovery opens new avenues for diagnosing and treating fatty liver disease based on an individual’s genetic makeup, offering hope for personalized therapeutic options.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
California Seniors and Disabled Face Threats to In-Home Care Amid Potential Medicaid Cuts
California seniors and disabled individuals are at risk of losing in-home care services amid proposed federal Medicaid cuts, threatening their independence and well-being.
Breakthrough in Childhood Leukemia Treatment: New Drug Combination Shows Promise
A groundbreaking drug combination developed by Cambridge scientists shows promise in treating childhood leukemia more effectively and with fewer side effects, potentially transforming future therapies.
Innovative Far-Red Dopamine Sensor Enables Real-Time Brain Imaging
A team from Peking University has developed a pioneering far-red fluorescent dopamine sensor that enables real-time, multiplex imaging of neurochemicals in the living brain, advancing neuroscience research.
Rise in Appendix Cancer Cases Among Younger Adults Highlights Changing Trends
Recent studies reveal a concerning rise in appendix cancer cases among younger adults, driven by lifestyle, environmental, and biological factors. Early awareness and diagnosis are vital for improving outcomes.